Grace Therapeutics, Inc. - CL A (ACST)

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / CL A
Shares, excl. options Q3 2024
1.16M
Holdings value Q3 2024
$3.48M
Value change Q3 2024
-$2.9M
Grand Portfolio weight change Q3 2024
0%
Number of holders
11
Number of buys Q3 2024
3
Number of sells Q3 2024
-5
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.16M $3.48M -$2.9M $3.00 11
2024 Q2 2.15M $6.3M +$2.59M $2.93 12
2024 Q1 1.27M $4.34M +$2.38M $3.43 10
2023 Q4 571K $1.65M -$34.4K $2.89 8
2023 Q3 518K $1.44M +$1.44M $2.78 8